Dynamic Medical Technologies Inc. AI Stock Analysis
Dynamic Medical Technologies Inc. (4138) AI Stock Analysis
Dynamic Medical Technologies Inc.
(TPEx:4138)
The score is supported primarily by a strong balance sheet, improved cash generation, and attractive valuation. However, declining revenue and profitability, together with weak-to-mixed technical momentum, reduce the overall outlook.
Dynamic Medical Technologies Inc. (4138) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- TWD 2.16B
- Dividend Yield
- 7.75%
- Average Volume (3M)
- 33.94K
- Price to Earnings (P/E)
- 15.7
- Beta (1Y)
- 0.07
- Revenue Growth
- -1.10%
- EPS Growth
- -16.90%
- Country
- TW
- Employees
- 85
- Sector
- General
- Sector Strength
- 55
- Industry
- Medical - Devices
Dynamic Medical Technologies Inc. Business Overview & Revenue Model
Company Description
Dynamic Medical Technologies Inc., encompassing its various subsidiaries, operates within the aesthetic industry throughout Taiwan and Hong Kong. The company's primary focus involves the commercialization and upkeep of cosmetic laser and light-based...
Dynamic Medical Technologies Inc. Financial Statement Overview
Summary
Financial performance is stable overall: the balance sheet is strong and cash generation improved, but declining revenue, earnings, and return on equity limit the score.
Income Statement
68PositiveBalance Sheet
82Very PositiveCash Flow
76Positive| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.40B | 1.39B | 1.57B | 1.59B | 1.29B | 1.03B |
| Gross Profit | 605.95M | 611.40M | 629.22M | 603.05M | 452.53M | 354.58M |
| EBITDA | 298.92M | 339.50M | 471.86M | 448.71M | 294.89M | 270.03M |
| Net Income | 146.07M | 152.06M | 205.39M | 210.32M | 137.11M | 123.21M |
Balance Sheet | ||||||
| Total Assets | 2.96B | 3.13B | 3.00B | 3.08B | 2.68B | 2.30B |
| Cash, Cash Equivalents and Short-Term Investments | 1.19B | 1.30B | 1.34B | 1.56B | 1.26B | 1.31B |
| Total Debt | 379.90M | 407.20M | 426.22M | 442.17M | 285.68M | 208.16M |
| Total Liabilities | 1.17B | 1.23B | 1.24B | 1.37B | 1.13B | 826.87M |
| Stockholders Equity | 1.58B | 1.67B | 1.54B | 1.54B | 1.39B | 1.28B |
Cash Flow | ||||||
| Free Cash Flow | 277.50M | 257.90M | 126.53M | 289.14M | 162.22M | 235.34M |
| Operating Cash Flow | 322.83M | 309.70M | 224.11M | 360.95M | 276.93M | 277.64M |
| Investing Cash Flow | -31.95M | -77.76M | -61.59M | -58.02M | -251.28M | -92.42M |
| Financing Cash Flow | -285.91M | -233.39M | -379.01M | -55.63M | -186.86M | -148.68M |
Dynamic Medical Technologies Inc. Peers Comparison
Overall Rating
TW:413870Outperform
TW:657466Neutral
TW:415564Neutral
TW:417560Neutral
TW:178452Neutral
TW:679640Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 70Outperform | TWD 2.15B | 15.66 | ― | 7.75% | -1.10% | -16.90% | |
| 66Neutral | TWD 2.39B | 8.69 | ― | 2.56% | 20.16% | 136.85% | |
| 64Neutral | TWD 2.19B | 10.00 | ― | 1.78% | -10.90% | ― | |
| 60Neutral | TWD 2.09B | 13.16 | ― | 6.00% | 2.49% | 5.18% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 52Neutral | TWD 2.38B | 40.18 | ― | 1.96% | 5.41% | -19.02% | |
| 40Underperform | TWD 2.04B | 123.00 | ― | 0.51% | 12.26% | ― |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TW:4138 | Dynamic Medical Technologies Inc. | 54.20 | -5.23 | -8.80% | |
| TW:1784 | Bionet Corp. | 45.00 | -56.02 | -55.46% | |
| TW:4155 | Ok Biotech Co., Ltd. | 16.90 | 1.37 | 8.84% | |
| TW:4175 | MedFirst Healthcare Services, Inc. (TW) | 50.00 | -3.90 | -7.23% | |
| TW:6574 | MIKOBEAUTE INTERNATIONAL CO., LTD. | 117.00 | 44.18 | 60.66% | |
| TW:6796 | Medimaging Integrated Solution Inc. | 49.20 | -39.14 | -44.31% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 09, 2026
